Company / SG&A per Share
Tandem Diabetes Care SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$6.72
FY2025
5-year range
$2.66 / $6.72
FY2021-FY2025
Trend
+12.9%
vs FY2024
Sector context
#63 of 156
Health Care
What the data says
At $6.72, Tandem Diabetes Care's sg&a per share ranks #94 of 156 in the Health Care sector. SG&A per Share has increased for 6 consecutive years, from $1.50 in FY2019 to $6.72 in FY2025.
Based on SEC 10-K filings.
6.72 in FY2025 with a 5-year CAGR of +30.5%.
Increased from $5.46 to $6.72 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +27.9%
- 5-Year CAGR
- +30.5%
- 10-Year CAGR
- -
Sector benchmark
#94 of 156 in Health CareTop 60% of 156This company $6.72 Sector average $11421.56
▼
-99.9% below sector average
Key checks
Key Insights
- Tandem Diabetes Care's sg&a per share has grown for 6 consecutive years.
- In FY2025, sg&a per share increased 12.9% year-over-year.
- Ranks #63 out of 156 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score -0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.72 | +12.9% |
| FY2024 | $5.95 | +8.8% |
| FY2023 | $5.46 | +70.2% |
| FY2022 | $3.21 | +20.7% |
| FY2021 | $2.66 | +50.1% |
| FY2020 | $1.77 | +18.0% |
| FY2019 | $1.50 | -81.7% |
| FY2018 | $8.19 | -67.6% |
| FY2017 | $25.28 | +823.4% |
| FY2016 | $2.74 | -17.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026